Investment Analysts’ Weekly Ratings Updates for Editas Medicine (EDIT)
A number of firms have modified their ratings and price targets on shares of Editas Medicine (NASDAQ: EDIT) recently: 3/1/2024 – Editas Medicine was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 2/29/2024 – Editas Medicine had its price target raised by analysts at Barclays PLC from $10.00 to $11.00. […]
More Stories
Shanghai Industrial (OTCMKTS:SGHIY) Hits New 12-Month High – Should You Buy?
Shanghai Industrial Holdings Limited (OTCMKTS:SGHIY – Get Free Report)’s stock price hit a new 52-week high on Monday . The...
Napco Security Technologies (NASDAQ:NSSC) Downgraded to Sell Rating by StockNews.com
Napco Security Technologies (NASDAQ:NSSC – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to...
StockNews.com Downgrades Virtus Investment Partners (NASDAQ:VRTS) to Hold
Virtus Investment Partners (NASDAQ:VRTS – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a...
Alarm.com (NASDAQ:ALRM) Upgraded by StockNews.com to “Buy” Rating
Alarm.com (NASDAQ:ALRM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a...
Eastman Chemical (NYSE:EMN) Downgraded by StockNews.com to Hold
Eastman Chemical (NYSE:EMN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a...
Telefônica Brasil (NYSE:VIV) Cut to Buy at StockNews.com
Telefônica Brasil (NYSE:VIV – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy”...